| Entry |
|
|---|
| Name |
Ketazolam (USAN/INN) |
|---|
| Formula |
C20H17ClN2O3
|
|---|
| Exact mass |
368.0928
|
|---|
| Mol weight |
368.8136
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Neuropsychiatric agent
DG01914 Anxiolytics, benzodiazepine derivatives
|
|---|
| Remark |
|
|---|
| Efficacy |
Minor tranquilizer |
|---|
| Comment |
Benzodiazepine derivative
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
N NERVOUS SYSTEM
N05 PSYCHOLEPTICS
N05B ANXIOLYTICS
N05BA Benzodiazepine derivatives
N05BA10 Ketazolam
D04650 Ketazolam (USAN/INN)
Drug groups [BR:br08330]
Neuropsychiatric agent
DG01914 Anxiolytics, benzodiazepine derivatives
D04650 Ketazolam
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
GABA (ionotropic)
GABR
D04650 Ketazolam (USAN/INN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 26
1 C1z C 30.0714 -20.1520
2 C8y C 29.2412 -19.0581
3 C8y C 29.5717 -17.7204
4 N1y N 30.8149 -17.1505
5 N1y N 31.4573 -20.1768
6 C5x C 32.0507 -17.7640
7 C1x C 32.3332 -19.1134
8 C8x C 28.5787 -16.7657
9 C8x C 27.2557 -17.1484
10 C8y C 26.9253 -18.4860
11 C8x C 27.9182 -19.4403
12 O5x O 33.0801 -16.8428
13 X Cl 25.5798 -18.8748
14 C8y C 28.3931 -20.8543
15 C8x C 28.3931 -22.2345
16 C8x C 27.1978 -20.1641
17 C8x C 26.0025 -20.8543
18 C8x C 26.0025 -22.2345
19 C8x C 27.1978 -22.9247
20 C1a C 30.8149 -15.7525
21 O2x O 29.3723 -21.3628
22 C2y C 30.0714 -22.5735
23 C2x C 31.4694 -22.5735
24 C5x C 32.1684 -21.3628
25 O5x O 33.5763 -21.3514
26 C1a C 29.3668 -23.7935
BOND 29
1 3 4 1
2 1 5 1
3 4 6 1
4 2 3 1
5 5 7 1
6 1 2 1
7 6 7 1
8 3 8 2
9 8 9 1
10 9 10 2
11 10 11 1
12 2 11 2
13 6 12 2
14 10 13 1
15 1 14 1
16 14 15 1
17 14 16 2
18 16 17 1
19 17 18 2
20 18 19 1
21 15 19 2
22 4 20 1
23 1 21 1
24 21 22 1
25 22 23 2
26 23 24 1
27 24 5 1
28 24 25 2
29 22 26 1
|
|---|
